DETERMINATION OF SIMULTANEOUS IRBESARTAN AND HYDROCHLOROTHIAZIDE BY ULTRAVIOLET SPECTROPHOTOMETRY WITH DUAL WAVELENGTH METHOD

Authors

  • Hafid Syahputra Faculty of Pharmacy, University of Sumatera Utara
  • M. Si. Apt Muchlisyam Professor, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia
  • M.S. Apt Masfria Professor, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia

DOI:

https://doi.org/10.22270/ajprd.v7i3.512

Keywords:

Irbesartan, hydrochlorothiazide, ultraviolet spectrophotometry, dual wavelength method

Abstract

Objective: The present study was aimed to develop a spectrophotometric method by dual wavelength method in simultaneous analysis of irbesartan and hydrochlorothiazide on tablet preparations without separation. Irbesartan and hydrochlorothiazide are a group of anti-hypertensive drugs that are very effective and safe to use to reduce blood pressure and edema. These drugs often given in combination with these active ingredients can cause problems in quantitative analysis for the quality control of preparations.

Methods: The study was carried out experimentally with a spectrophotometric method, one of which was dual wavelength method and then tested its validity based on validation parameters, namely linearity, accuracy, precision, LOD and LOQ and intraday and interday. Then, this method of irbesartan and hydrochlorothiazide in tablet preparations.

Results: The results of the study were showed that the application of dual wavelength method on the concentration was carried out at λ 263.4 nm and 281 nm for irbesartan and at λ 243.4 nm and 247.6 nm for hydrochlorothiazide. The results obtained by irbesartan and hydrochlorothiazide on tablets were (108.04 ± 2.696) and (94.28 ± 4.48)% respectively, and with good precision and accuracy.

Conclusions: The ultraviolet spectrophotometry method is dual wavelength method successfully applied for the determination of the concentration of irbesartan and hydrochlorothiazide in tablets.

Downloads

Download data is not yet available.

Author Biographies

Hafid Syahputra, Faculty of Pharmacy, University of Sumatera Utara

Faculty of Pharmacy, University of Sumatera Utara,Indonesia

M. Si. Apt Muchlisyam, Professor, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia

Professor, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia

M.S. Apt Masfria, Professor, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia

Professor, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Sumatera Utara, Medan, Indonesia

References

1. Moffat AC, Osselton MD, Widdop B. Clarke’s Analysis of Drugs and Poisons. 4th ed. London: Pharmaceutical Press; 2011. 73–85 p.
2. Raskin P, Guthrie R, Flack JM, Reeves RA, Saini R. The long-term antihypertensive activity and tolerability of irbesartan with hydrochlorothiazide. J Hum Hypertension. 1999;(13):683–7.
3. Vahora S, Mehta F, Chhalotiya U, Shah D. Dual Wavelength Spectrophotometric Method for Estimation of Cilnidipine and Telmisartan in Their Combined Dosage Form. Res Rev J Pharm Anal. 2014;3(2):22–9.
4. Bindaiya S, Bankey S, D.jain. Simultaneous Determination of nitazoxanide and ofloxacine in Tablet Dosage Form by Ultraviolet Spectrophotometry (Dual Wavelength Method). intJChemTechRes. 2010;1(2):11–5.
5. Pradhan PK, Rajput PN, Kumar N, Joshi B, Upadhyay UM. Simultaneous estimation of Flurbiprofen and Gatifloxacin by dual wavelength UV spectroscopy method in an eye drops. Int J Pharm Sci Rev Res. 2014;27(2):96–9.
6. Kamal AH, El-malla SF, Hammad SF. A Review on Uv Spectrophotometric Methods for Simultaneous Multicomponent Analysis. Eur J Pharm Med Res. 2016;3(2):348–60.
7. Harmita. Petunjuk Pelaksanaan Validasi Metode dan Cara Perhitungannya. Maj Ilmu Kefarmasian. 2004;I(3):117–35.
8. Ermer J, John JH. Method Validation in Pharmaceutical Analysis: A Guide to Best Practice [Internet]. Weinheim, FRG: Wiley-VCH Verlag GmbH & Co. KGaA; 2005. 1–403 p. Available from: http://doi.wiley.com/10.1002/3527604685

Published

2019-06-15

How to Cite

Syahputra, H., Muchlisyam, M. S. A., & Masfria, M. A. (2019). DETERMINATION OF SIMULTANEOUS IRBESARTAN AND HYDROCHLOROTHIAZIDE BY ULTRAVIOLET SPECTROPHOTOMETRY WITH DUAL WAVELENGTH METHOD. Asian Journal of Pharmaceutical Research and Development, 7(3), 1–4. https://doi.org/10.22270/ajprd.v7i3.512